CME vs CBOE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

CME

59.1
AI Score
VS
CME Wins

CBOE

57.4
AI Score

Investment Advisor Scores

CME

59score
Recommendation
HOLD

CBOE

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CME CBOE Winner
Forward P/E 21.9298 21.9298 Tie
PEG Ratio 4.7092 2.3792 CBOE
Revenue Growth 0.8% 22.9% CBOE
Earnings Growth 2.5% 50.2% CBOE
Tradestie Score 59.1/100 57.4/100 CME
Profit Margin 63.4% 26.7% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CME 1M: -5.3% · 3M: +12.1% CBOE 1M: -7.8% · 3M: +10.7%

Current Technical Phase

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.6 · Price: $263.14

CBOE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.2 · Price: $271.26

Fundamentals Snapshot

Metric CME CBOE
Market Cap — —
Forward P/E 20.4 17.8
Trailing P/E 22.2 21.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 1.0% 0.5%
Operating Margin 0.7% 0.3%
EPS 11.93 12.83
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.